L-Carnitine 500 mg

DRAGON PHARMA L-CARNITINE

Dragon Pharma's L-Carnitine 500 mg represents the pinnacle of pharmaceutical-grade levocarnitine supplementation. Specifically formulated for athletes, bodybuilders, and fitness enthusiasts in the United States, this lyophilized powder offers unparalleled purity and bioavailability. As a naturally occurring amino acid derivative, L-Carnitine plays a crucial role in energy metabolism by transporting long-chain fatty acids into mitochondria for β-oxidation. Dragon Pharma's commitment to quality ensures each 2 mL vial contains precisely measured 500 mg of active Levocarnitine, with independent third-party laboratory testing confirming potency at 525.08 mg per vial, exceeding labeled claims.

DRUG COMPOSITION

Each 2 mL vial contains 500 mg of Levocarnitine (L-Carnitine) as a white to off-white lyophilized powder. The product contains no additional excipients, fillers, or preservatives, ensuring maximum purity and minimizing potential adverse reactions. The lyophilization process removes water through freeze-drying, resulting in a stable powder that maintains potency throughout its shelf life. This pharmaceutical-grade formulation ensures rapid reconstitution and complete absorption when prepared with sterile water or bacteriostatic water.

PHARMACEUTICAL FORM

Lyophilized powder for injection in a sterile 2 mL glass vial with a rubber stopper and aluminum seal. The lyophilized form offers several advantages over liquid preparations: enhanced stability, extended shelf life, reduced risk of bacterial contamination, and precise dosing. The powder reconstitutes quickly with appropriate solvents, forming a clear, colorless solution ready for intramuscular or subcutaneous administration.

PHARMACEUTICAL GROUP AND ATC CODE

L-Carnitine belongs to the therapeutic category of other cardiac preparations (ATC code: C01EB). According to the WHO Anatomical Therapeutic Chemical Classification System, it falls under cardiac therapy medications, specifically as a metabolic agent. In sports medicine and performance enhancement, it's classified as a fat metabolism optimizer and endurance supplement.

PHARMACOLOGICAL PROPERTIES

Levocarnitine facilitates the transport of long-chain fatty acids across the inner mitochondrial membrane, enabling β-oxidation and subsequent ATP production. This mechanism provides several pharmacological benefits: enhanced fatty acid utilization for energy, reduced lactic acid accumulation during exercise, improved recovery between training sessions, and optimization of the aerobic energy system. Research published in the Journal of the International Society of Sports Nutrition demonstrates that L-Carnitine supplementation can increase muscle carnitine content, which enhances athletic performance by sparing glycogen, reducing metabolic stress, and decreasing muscle damage markers.

THERAPEUTICAL INDICATIONS

Primary therapeutic indications include treatment of primary and secondary carnitine deficiencies. In sports and fitness applications, Dragon Pharma L-Carnitine 500 mg is indicated for: accelerating fat loss during cutting cycles, improving exercise performance and endurance, enhancing recovery between workouts, reducing muscle soreness and damage, supporting cardiovascular health during intense training periods, and optimizing metabolic function in calorie-restricted diets. It's particularly valuable during pre-contest preparation for bodybuilders and during endurance training phases for athletes.

DOSES AND METHOD OF ADMINISTRATION

For performance enhancement and fat loss, the recommended dosage is 500-1000 mg daily, typically administered as a single injection or divided into two doses. Reconstitute the lyophilized powder with 1-2 mL of sterile water or bacteriostatic water. The solution can be administered via intramuscular injection in large muscle groups (glutes, quadriceps, deltoids) or subcutaneously in abdominal or thigh adipose tissue. Intramuscular administration may provide more localized fat-burning effects in the injection area. For therapeutic use in carnitine deficiency, dosage should be determined by a healthcare professional based on individual needs and plasma carnitine levels.

CYCLE/STACKING

L-Carnitine stacks synergistically with various performance-enhancing compounds to maximize results. For cutting cycles, combine with Clenbuterol for enhanced thermogenesis and fat oxidation. Stack with GW501516 to further improve endurance and fatty acid utilization. During recomp phases, combine with Testabol 400 to maintain muscle mass while reducing body fat. For endurance athletes, stack with EQ 300 to increase red blood cell production and oxygen delivery. During post-cycle therapy, combine with Nolvadex while using L-Carnitine to help maintain metabolic rate during recovery.

POST CYCLE THERAPY

L-Carnitine serves as an excellent adjunct during post-cycle therapy (PCT) by helping maintain metabolic rate and energy levels when endogenous testosterone production is recovering. During PCT, continue L-Carnitine at 500 mg daily to support fat metabolism, as many individuals experience metabolic slowdown when discontinuing anabolic compounds. The energy-enhancing properties help combat the fatigue often associated with PCT, while the cardiovascular benefits support heart health during hormonal transitions. Combine with proper PCT medications and a calorie-controlled diet to preserve lean mass while continuing fat loss.

SIDE EFFECTS

L-Carnitine is generally well-tolerated with minimal side effects when used at recommended doses. Some individuals may experience mild gastrointestinal discomfort, nausea, or abdominal cramps, particularly with higher doses. Injection site reactions may include pain, redness, or swelling. Rare side effects include body odor changes (often described as "fishy") due to trimethylamine production. Extremely high doses (exceeding 3,000 mg daily) may cause diarrhea, vomiting, or seizures in sensitive individuals. These side effects typically resolve with dose reduction or discontinuation.

CONTRAINDICATIONS

Contraindications include known hypersensitivity to Levocarnitine or any component of the formulation. Use with caution in individuals with seizure disorders, as high doses may lower seizure threshold. Not recommended for individuals with severe renal impairment without medical supervision. Pregnant or breastfeeding women should avoid use unless specifically prescribed by a physician for therapeutic carnitine deficiency. Individuals with mitochondrial disorders should consult with a healthcare provider before use.

OVERDOSE

Acute overdose of L-Carnitine is rare due to its water-soluble nature and efficient renal excretion. Symptoms of extreme overdose may include severe diarrhea, vomiting, abdominal pain, and in rare cases, seizures. Treatment is supportive and symptomatic. Discontinue administration, ensure adequate hydration, and monitor electrolyte balance. In cases of accidental injection of extremely high doses, seek medical attention for assessment and supportive care. The LD50 in animal studies exceeds 5,000 mg/kg body weight, indicating a wide safety margin.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE

Use aseptic technique when reconstituting and administering injections to prevent infection. Rotate injection sites to prevent lipohypertrophy or tissue damage. Monitor for signs of allergic reaction, particularly in individuals with multiple drug sensitivities. Individuals with diabetes should monitor blood glucose levels, as L-Carnitine may enhance insulin sensitivity. Those with hypothyroidism should use with caution, as carnitine may interfere with thyroid hormone action at high doses. Avoid concurrent use with valproic acid, which may increase carnitine requirements.

INTERACTIONS WITH OTHER DRUGS

L-Carnitine may potentiate the effects of anticoagulants like warfarin, requiring closer monitoring of INR values. It may enhance the glucose-lowering effects of antidiabetic medications. Concurrent use with thyroid hormones may require dosage adjustments. Valproic acid and other anticonvulsants may increase carnitine excretion, potentially necessitating higher supplementation doses. When stacking with other performance-enhancing drugs, be aware of potential additive effects on metabolic rate and cardiovascular parameters.

PRESENTATION, PACKAGING

Dragon Pharma L-Carnitine 500 mg is presented in individual sterile glass vials with gray rubber stoppers and purple aluminum seals. Each vial contains lyophilized powder equivalent to 500 mg Levocarnitine. The product is available in packs of 10 vials with included sterile water for reconstitution. Each vial is individually labeled with product name, strength, batch number, and expiration date. The packaging includes tamper-evident features and is shipped in discreet, protective materials.

STORAGE

Store unopened vials at controlled room temperature between 15°C and 25°C (59°F-77°F). Protect from light and moisture. Do not freeze. After reconstitution, use immediately or store in refrigerator for up to 24 hours if using bacteriostatic water. Discard any solution that appears cloudy, discolored, or contains particulate matter. Keep out of reach of children and pets.

DELIVERY TO THE USA

All orders to the United States are shipped discreetly with tracking information provided. We utilize multiple shipping methods to ensure reliable delivery, with most orders arriving within 7-14 business days. Packaging is plain and unmarked to protect customer privacy. We offer reshipment guarantees for orders that encounter customs issues, though seizure rates are extremely low for L-Carnitine as it's not a controlled substance in most jurisdictions.

LEGAL STATUS

In the United States, L-Carnitine is classified as a dietary supplement and is legal for personal use without a prescription. It is not listed as a controlled substance under the Controlled Substances Act. However, state regulations may vary, and it's the buyer's responsibility to ensure compliance with local laws. For athletic competitions, check specific sports federation rules, as some organizations may have restrictions on injectable forms.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Dragon Pharma, Europe

EXTERNAL LINKS

• National Library of Medicine - Levocarnitine Pharmacology and Therapeutics

PROFILE

• Chemical name: (3R)-3-Hydroxy-4-(trimethylazaniumyl)butanoate
• Chemical formula: C₇H₁₅NO₃
• Molecular weight: 161.20 g/mol
• Percentage of anabolic activity: 0% (Not anabolic)
• Percentage of androgenic activity: 0% (Not androgenic)
• Active half life: 2-15 hours (dose and route dependent)
• Recommended dosage: 500-1000 mg daily
• Acne: None reported
• Bloating (water retention): None reported
• HBR (Hepatobiliary-related): No hepatotoxicity
• Hepatic toxicity: None
• Aromatization: Does not aromatize
• Detection time: 24-48 hours
• Anabolic/Androgenic Ratio: N/A

Third Party Lab Test

2025-09-12

View Result

525.08 mg